{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:25:10Z","timestamp":1773815110142,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1025142"],"award-info":[{"award-number":["GNT1025142"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1120431"],"award-info":[{"award-number":["GNT1120431"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1173346"],"award-info":[{"award-number":["GNT1173346"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2014122"],"award-info":[{"award-number":["GNT2014122"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canep.2025.102961","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:29:41Z","timestamp":1763695781000},"page":"102961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) study"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-3060","authenticated-orcid":false,"given":"Azam","family":"Majidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-8462","authenticated-orcid":false,"given":"Renhua","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-1414","authenticated-orcid":false,"given":"Susan J.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5602-6646","authenticated-orcid":false,"given":"Tanya L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-4744","authenticated-orcid":false,"given":"Anna","family":"DeFazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-795X","authenticated-orcid":false,"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1350-7508","authenticated-orcid":false,"given":"Peter","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-5930","authenticated-orcid":false,"given":"Penelope M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102961_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.canep.2025.102961_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.canep.2025.102961_bib3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","article-title":"The renin\u2013angiotensin system and malignancy","volume":"29","author":"Ager","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canep.2025.102961_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.canep.2025.102961_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canep.2025.102961_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2016.04.004","article-title":"Beta blockers and cancer prognosis \u2013 The role of immortal time bias: A systematic review and meta-analysis","volume":"47","author":"Weberpals","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canep.2025.102961_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ygyno.2020.03.028","article-title":"Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis","volume":"157","author":"Majidi","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1055\/s-0042-115016","article-title":"The clinical relevance of beta blockers in ovarian carcinoma: a systematic review","volume":"76","author":"Hefner","year":"2016","journal-title":"Geburtshilfe und Frauenheilkd."},{"key":"10.1016\/j.canep.2025.102961_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology","volume":"167","author":"Suissa","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2025.102961_bib10","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1002\/cncr.29394","article-title":"Are beta-blockers on the therapeutic horizon for ovarian cancer treatment?","volume":"121","author":"Bunch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2025.102961_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00432-016-2278-1","article-title":"\u03b2-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives","volume":"143","author":"Coelho","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/2001-1326-1-16","article-title":"Contribution of uric acid to cancer risk, recurrence, and mortality","volume":"1","author":"Fini","year":"2012","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canep.2025.102961_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1096\/fj.15-277798","article-title":"The \u03b22-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion","volume":"30","author":"Pon","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.canep.2025.102961_bib14","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.4049\/jimmunol.158.9.4200","article-title":"Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help","volume":"158","author":"Sanders","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.canep.2025.102961_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/10618600.1993.10474623","article-title":"Comparison of multivariate matching methods: Structures, distances, and algorithms","volume":"2","author":"Gu","year":"1993","journal-title":"J. Comput. Graph. Stat."},{"key":"10.1016\/j.canep.2025.102961_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J."},{"key":"10.1016\/j.canep.2025.102961_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/pst.2004","article-title":"Restricted mean survival time as a summary measure of time to event outcome","volume":"19","author":"Hasegawa","year":"2020","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.canep.2025.102961_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2017.08.012","article-title":"Bevacizumab-induced hypertension: clinical presentation and molecular understanding","volume":"182","author":"Li","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canep.2025.102961_bib19","unstructured":"Lambart P.C. stpm2. Available from URL: \u3008https:\/\/pclambert.net\/software\/stpm2\/\u3009."},{"key":"10.1016\/j.canep.2025.102961_bib20","unstructured":"Lambart P.C. stpm2_standsurv. Available from URL: \u3008https:\/\/pclambert.net\/software\/stpm2_standsurv\/\u3009 [accessed."},{"key":"10.1016\/j.canep.2025.102961_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2019.05.030","article-title":"Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer","volume":"154","author":"Harding","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib22","first-page":"469","article-title":"History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium","volume":"28","author":"Minlikeeva","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2025.102961_bib23","first-page":"645","article-title":"Impact of angiotensin receptor bockers, beta blockers, calcium channel blockers and thiazide diuretics on survival of ovariancancer patients","volume":"52","author":"Cho","year":"2020","journal-title":"Cancer Research Treatment Official Journal Korean Cancer Association"},{"key":"10.1016\/j.canep.2025.102961_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092087","article-title":"Antihypertensive drug use and the risk of ovarian cancer death among finnish ovarian cancer patients-a nationwide cohort study","volume":"13","author":"Santala","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canep.2025.102961_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2021.09.009","article-title":"Antihypertensive medication use and ovarian cancer survival","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12905-024-02983-7","article-title":"Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study","volume":"24","author":"Everatt","year":"2024","journal-title":"BMC Women's. Health"},{"key":"10.1016\/j.canep.2025.102961_bib27","article-title":"Perioperative beta-blocker supply and survival in women with epithelial ovarian cancer and a history of cardiovascular conditions","volume":"0","author":"Spilsbury","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.660943","article-title":"The use of antihypertensive drugs as coadjuvant therapy in cancer","volume":"11","author":"Carlos-Escalante","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canep.2025.102961_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.canep.2025.102961_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2018.07.021","article-title":"Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein","volume":"434","author":"Saikawa","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canep.2025.102961_bib31","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canep.2025.102961_bib32","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:32:25Z","timestamp":1773811945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125002218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S1877782125002218"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102961","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102961"}}